Clinical Trial

Development of Optical Biometer

Study acronym: CH-0203
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 8, 2026 (before its estimated February 28, 2026 completion). Its status may not reflect the trial's current state.
Summary
The Helioscope (Cassini Technologies B.V.) is a novel device under development that aims at combining LED-based corneal topography and SS-OCT to provide accurate and fast measurements of both the corneal shape and the ocular biometry. To that end, the hardware and software of the Cassini color-LED topographer (Cassini Technologies B.V.) is combined with a novel SS-OCT device. While the new Helioscope can largely be evaluated using data acquired with healthy eyes, one of its main use-cases is providing input for IOL power formulae for cataract surgery. Thus, it is essential that the device can perform measurements in eyes with (dense) cataract. As cataract changes the optical properties of the crystalline lens and the OCT measurement is optical, this is not a given. This study therefore seeks a dataset of Helioscope measurements performed in eyes with cataract that can be used to develop the software algorithms of the Helioscope.
Trial Details
NCT Number NCT07325162
Lead Sponsor Cassini Technologies
Conditions Cataract and IOL Surgery
Enrollment 100 participants
Start Date 2025-11-07
Primary Completion 2026-02-28 (estimated)
Study Completion 2026-03-30 (estimated)
Updated on ClinicalTrials.gov 2026-01-08